In my notes I have this from investor update feb 2 24 OPOA IND filing Q2 2024 OPOA Q4 24 GLP studies begin
Kidney: start trials end of 24 (so they must be working on animal tox for now.) And they are proving uptake in the kidney in one healthy monkey Q2 April May begin trial of safety in NHP and work out max tol dose and see how it transfers to kidney tissue. RP11 in q4 they will compare the natural history study pts with the injected patients, and could get a signal for efficacy.
so in summary, there are lots of steps this year and each one of them has the potential to attract more investors and instos. given the cap raise is done, it is possible on market buying will outstrip selling this time around.
exciting times. Given the way the sp has behaved post raise I have confidence that the buyers are circling…..
PYC Price at posting:
9.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)